Ai Yoshihara

Treatment of Graves' Disease with Antithyroid Drugs in the First Trimester of Pregnancy and the Prevalence of Congenital Malformation

Ai Yoshihara, JaedukYoshimura Noh, Takuhiro Yamaguchi et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 233 citations

Medicine, Maternal Health, Obstetrics +13

Antithyroid Drug Treatment for Graves' Disease in Children: A Long-Term Retrospective Study at a Single Institution

Hidemi Ohye, Akinobu Minagawa, Jaeduk Yoshimura Noh et al. · Thyroid · 2013 · 107 citations

Medicine, Endocrinology, Pediatrics +14

Expression of Type 5 Somatostatin Receptor in TSH-secreting Pituitary Adenomas: A Possible Marker for Predicting Long-term Response to Octreotide Therapy

Ai Yoshihara, Osamu Isozaki, Naomi Hizuka et al. · Endocrine Journal · 2007 · 60 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan

Ai Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe et al. · Thyroid · 2015 · 54 citations

Medicine, Endocrinology, Obstetrics +14

Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves’ Disease in Japan

Nami Suzuki, Jaeduk Yoshimura Noh, Marino Hiruma et al. · Thyroid · 2019 · 49 citations

Medicine, Endocrinology, Pharmacology +17